| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5', 3'-nucleotidase, cytosolic | 0.729 | 0.231 | 2.7E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
disease | 0.390 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
acidic nuclear phosphoprotein 32 family member A | 0.674 | 0.577 | 0.99 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.600 | limited | 0.984 | 0 | 0 | 2002 | 2020 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.390 | None | 0.889 | 1 | 0 | 2006 | 2018 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
disease | 0.400 | None | 0.941 | 1 | 0 | 1999 | 2017 | ||||||||
|
aldo-keto reductase family 1 member B10 | 0.546 | 0.769 | 7.6E-09 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.800 | strong | 0.972 | 7 | 0 | 1990 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway 2 | 0.582 | 0.654 | 1.00 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
archaelysin family metallopeptidase 2 pseudogene 1 | 1.000 | 0.077 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
aryl hydrocarbon receptor nuclear translocator | 0.575 | 0.692 | 1.00 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2011 | 2015 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.490 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.520 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 10 | 1.000 | 0.077 | 7.7E-34 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 12 | 0.610 | 0.654 | 2.9E-15 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 13 | 0.722 | 0.308 | 8.8E-114 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 5 | 0.736 | 0.423 | 4.8E-27 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 6 | 0.861 | 0.231 | 5.1E-27 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 8 | 0.821 | 0.231 | 1.6E-52 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 9 | 0.839 | 0.154 | 9.5E-48 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.600 | None | 0.960 | 2 | 0 | 1990 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 10 | 0.716 | 0.423 | 2.9E-08 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2020 |